These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21384047)

  • 1. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.
    Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I
    Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.
    Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I
    Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.
    Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I
    Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.
    Kos I; Rebouças JS; DeFreitas-Silva G; Salvemini D; Vujaskovic Z; Dewhirst MW; Spasojević I; Batinić-Haberle I
    Free Radic Biol Med; 2009 Jul; 47(1):72-8. PubMed ID: 19361553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOD-like activity of Mn(II) beta-octabromo-meso-tetrakis(N-methylpyridinium-3-yl)porphyrin equals that of the enzyme itself.
    DeFreitas-Silva G; Rebouças JS; Spasojević I; Benov L; Idemori YM; Batinić-Haberle I
    Arch Biochem Biophys; 2008 Sep; 477(1):105-12. PubMed ID: 18477465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology.
    Tovmasyan A; Weitner T; Sheng H; Lu M; Rajic Z; Warner DS; Spasojevic I; Reboucas JS; Benov L; Batinic-Haberle I
    Inorg Chem; 2013 May; 52(10):5677-91. PubMed ID: 23646875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
    Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I
    Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
    Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
    Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.
    Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
    Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
    Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
    Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I
    Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
    Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.
    Rebouças JS; Spasojević I; Batinić-Haberle I
    J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
    Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
    Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier.
    Rebouças JS; DeFreitas-Silva G; Spasojević I; Idemori YM; Benov L; Batinić-Haberle I
    Free Radic Biol Med; 2008 Jul; 45(2):201-10. PubMed ID: 18457677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of SOD-deficient Escherichia coli by manganese porphyrin mimics of superoxide dismutase activity.
    Okado-Matsumoto A; Batinić-Haberle I; Fridovich I
    Free Radic Biol Med; 2004 Aug; 37(3):401-10. PubMed ID: 15223074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High lipophilicity of meta Mn(III) N-alkylpyridylporphyrin-based superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli.
    Kos I; Benov L; Spasojević I; Rebouças JS; Batinić-Haberle I
    J Med Chem; 2009 Dec; 52(23):7868-72. PubMed ID: 19954250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy.
    Batinić-Haberle I; Cuzzocrea S; Rebouças JS; Ferrer-Sueta G; Mazzon E; Di Paola R; Radi R; Spasojević I; Benov L; Salvemini D
    Free Radic Biol Med; 2009 Jan; 46(2):192-201. PubMed ID: 19007878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrostatic contribution in the catalysis of O2*- dismutation by superoxide dismutase mimics. MnIIITE-2-PyP5+ versus MnIIIBr8T-2-PyP+.
    Spasojevic I; Batinic-Haberle I; Reboucas JS; Idemori YM; Fridovich I
    J Biol Chem; 2003 Feb; 278(9):6831-7. PubMed ID: 12475974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.
    Celic T; Španjol J; Bobinac M; Tovmasyan A; Vukelic I; Reboucas JS; Batinic-Haberle I; Bobinac D
    Free Radic Res; 2014 Dec; 48(12):1426-42. PubMed ID: 25185063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.